UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$188M |
| 2 |
Yelp
YELP
|
+$182M |
| 3 |
General Motors
GM
|
+$141M |
| 4 |
American Express
AXP
|
+$138M |
| 5 |
Comcast
CMCSA
|
+$116M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
eBay
EBAY
|
+$331M |
| 2 |
Crown Castle
CCI
|
+$303M |
| 3 |
Cardinal Health
CAH
|
+$204M |
| 4 |
Gilead Sciences
GILD
|
+$157M |
| 5 |
Apple
AAPL
|
+$150M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.6% |
| 2 | Healthcare | 13.9% |
| 3 | Technology | 13.4% |
| 4 | Industrials | 10.1% |
| 5 | Consumer Discretionary | 9.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1826
Pilgrim's Pride
PPC
$6.57B
| $439K | ﹤0.01% |
27,025
-3,000
| -10% | -$47K |
|
1827
Encore Capital Group
ECPG
$2.11B
| $437K | ﹤0.01% |
8,699
+100
| +1% | +$4.76K |
|
1828
Monolithic Power Systems
MPWR
$67.8B
| $437K | ﹤0.01% |
12,600
| – | – |
|
|
WAC
1829
DELISTED
Walter Investment Mgt Corp
WAC
| $435K | ﹤0.01% |
12,299
+300
| +3% | +$11.3K |
|
|
MKTG
1830
DELISTED
RESPONSYS INC COM STK (CA)
MKTG
| $433K | ﹤0.01% |
15,798
+1,300
| +9% | +$23.7K |
|
1831
RBC Bearings
RBC
$17.9B
| $432K | ﹤0.01% |
6,100
+500
| +9% | +$33.6K |
|
|
CLNY
1832
DELISTED
Colony Capital, Inc.
CLNY
| $432K | ﹤0.01% |
21,298
+800
| +4% | +$16.1K |
|
|
BDBD
1833
DELISTED
BOULDER BRANDS INC
BDBD
| $431K | ﹤0.01% |
27,198
-1,600
| -6% | -$24.8K |
|
1834
Clearwater Paper
CLW
$376M
| $430K | ﹤0.01% |
8,199
-1,100
| -12% | -$56.3K |
|
|
CMD
1835
DELISTED
Cantel Medical Corporation
CMD
| $429K | ﹤0.01% |
12,650
-400
| -3% | -$13.9K |
|
|
IMGN
1836
DELISTED
Immunogen Inc
IMGN
| $428K | ﹤0.01% |
29,197
-900
| -3% | -$13.8K |
|
|
CLVS
1837
DELISTED
Clovis Oncology, Inc.
CLVS
| $428K | ﹤0.01% |
7,100
+2,400
| +51% | +$131K |
|
|
QGENF
1838
DELISTED
QIAGEN NV
QGENF
| $428K | ﹤0.01% |
17,966
| – | – |
|
1839
Ironwood Pharmaceuticals
IRWD
$695M
| $426K | ﹤0.01% |
43,816
+13,850
| +46% | +$124K |
|
|
MDC
1840
DELISTED
M.D.C. Holdings, Inc.
MDC
| $426K | ﹤0.01% |
18,331
-1,945
| -10% | -$41.2K |
|
1841
Veeco
VECO
$3.19B
| $425K | ﹤0.01% |
12,899
-33,224
| -72% | -$1.07M |
|
1842
Hecla Mining
HL
$11B
| $424K | ﹤0.01% |
137,818
-1,900
| -1% | -$5.74K |
|
1843
Methode Electronics
MEI
$588M
| $424K | ﹤0.01% |
12,398
-6,100
| -33% | -$177K |
|
|
ENLC
1844
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
| $424K | ﹤0.01% |
+11,722
| New | +$349K |
|
|
FOE
1845
DELISTED
Ferro Corporation
FOE
| $423K | ﹤0.01% |
32,997
-15,304
| -32% | -$186K |
|
|
KNGT
1846
DELISTED
KNIGHT TRANSPORTATION INC
KNGT
| $423K | ﹤0.01% |
23,079
+1,100
| +5% | +$20.2K |
|
1847
Children's Place
PLCE
$61.2M
| $422K | ﹤0.01% |
7,399
-100
| -1% | -$5.42K |
|
|
WBMD
1848
DELISTED
WebMD Health Corp.
WBMD
| $422K | ﹤0.01% |
10,678
-1,000
| -9% | -$36.1K |
|
1849
AAR Corp
AIR
$5.79B
| $420K | ﹤0.01% |
14,998
-300
| -2% | -$8.76K |
|
|
AVL
1850
DELISTED
Avalon Rare Metals, Inc. Ordinary Shares (Canada)
AVL
| $420K | ﹤0.01% |
769,808
+78,729
| +11% | +$56.2K |
|
Similar funds
UBS AM's Q4 2013 Portfolio in Review
As of Q4 2013, UBS AM held 2,637 positions worth $87.5B, up 8.1% from $80.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS AM's Q4 2013 filing shows 130 new, 1,010 increased, 1,128 reduced and 103 closed positions. Its largest new stake was Trip.com Group: 2,309,000 shares worth $57.3M. The largest sale was eBay, an estimated $331M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Technology.
- UBS AM's largest Q4 2013 buy was Trip.com Group: 2,309,000 shares worth $57.3M.
- UBS AM added most to Regeneron Pharmaceuticals in Q4 2013, an estimated $188M increase.
- UBS AM's biggest Q4 2013 reduction was eBay, cutting an estimated $331M.
- UBS AM fully exited DELL INC in Q4 2013, selling an estimated $62.9M.
- UBS AM's ten largest holdings make up 14% of its $87.5B portfolio in Q4 2013.
- UBS AM opened 130 new positions and closed 103 in Q4 2013.
- UBS AM's portfolio value rose 8.1% quarter-over-quarter to $87.5B.
Based on UBS AM's 13F filing for Q4 2013, filed 31 Jan 2014.